Tannic Acid Inhibits CaMKII-β Kinase Activity In Vitro and Displays Preclinical Anti-Tumor Activity in Ovarian Cancer Models

Ovarian cancer (OC) is characterized by delayed clinical diagnosis, intrinsic/acquired platinum chemoresistance, and a high postoperative recurrence rate, highlighting an unmet clinical need for new targeted therapeutic strategies. Herein, we integrated pan-cancer transcriptomic profiling, clinical tissue immunohistochemistry, siRNA-mediated gene silencing, co-immunoprecipitation, structure-based virtual ligand screening, in vitro kinase activity assays, cellular viability functional assays, and SK-OV-3 xenograft mouse models to preliminarily reveal that CaMKII-β may mediate OC progression and characterize the anti-tumor potency of tannic acid. We preliminarily found that CaMKII-β is upregulated in OC patient tissues, and its elevated expression correlates with unfavorable overall survival. Genetic depletion of CaMKII-β attenuated OC cell viability both in vitro and in vivo via interfering with RAS-related signaling and suppressing downstream PI3K, AKT, and NF-κB transcriptional signaling cascades. Structure-based virtual screening identified tannic acid as a candidate CaMKII-β inhibitor with an IC50 value of 217 nM. Functional cellular assays demonstrated that tannic acid suppresses OC cell viability in a dose-dependent manner, accompanied by reduced phosphorylation of PI3K, AKT, and NF-κB, while the total protein levels of these signaling intermediates remain unaltered. In vivo intraperitoneal injection of tannic acid impeded the growth of SK-OV-3 xenograft tumors without inducing measurable systemic weight loss in host mice. In summary, CaMKII-β may contribute to malignant progression of OC through its association with RAS-related signaling, and tannic acid shows pre-clinical preliminary anti-tumor activity associated with CaMKII-β-related signaling in OC. Further mechanistic validation, pharmacokinetic, toxicological, and clinically relevant in vivo studies are required to evaluate its translational potential.

Authors

Institutions

Publication Details

Journal
Cells
Published
2026-11-12
DOI
https://doi.org/10.3390/cells15222059
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tannic Acid Inhibits CaMKII-β Kinase Activity In Vitro and Displays Preclinical Anti-Tumor Activity in Ovarian Cancer Models

Jin Chang, 忠 旭山, Ruqi Liang, Yizhao Chen et al.
Cells
Ovarian cancer diagnosis and treatment
article

Tannic Acid Inhibits CaMKII-β Kinase Activity In Vitro and Displays Preclinical Anti-Tumor Activity in Ovarian Cancer Models

Jin Chang, 忠 旭山, Ruqi Liang, Yizhao Chen, Yaru Miao
article en

Abstract

Ovarian cancer (OC) is characterized by delayed clinical diagnosis, intrinsic/acquired platinum chemoresistance, and a high postoperative recurrence rate, highlighting an unmet clinical need for new targeted therapeutic strategies. Herein, we integrated pan-cancer transcriptomic profiling, clinical tissue immunohistochemistry, siRNA-mediated gene silencing, co-immunoprecipitation, structure-based virtual ligand screening, in vitro kinase activity assays, cellular viability functional assays, and SK-OV-3 xenograft mouse models to preliminarily reveal that CaMKII-β may mediate OC progression and characterize the anti-tumor potency of tannic acid. We preliminarily found that CaMKII-β is upregulated in OC patient tissues, and its elevated expression correlates with unfavorable overall survival. Genetic depletion of CaMKII-β attenuated OC cell viability both in vitro and in vivo via interfering with RAS-related signaling and suppressing downstream PI3K, AKT, and NF-κB transcriptional signaling cascades. Structure-based virtual screening identified tannic acid as a candidate CaMKII-β inhibitor with an IC50 value of 217 nM. Functional cellular assays demonstrated that tannic acid suppresses OC cell viability in a dose-dependent manner, accompanied by reduced phosphorylation of PI3K, AKT, and NF-κB, while the total protein levels of these signaling intermediates remain unaltered. In vivo intraperitoneal injection of tannic acid impeded the growth of SK-OV-3 xenograft tumors without inducing measurable systemic weight loss in host mice. In summary, CaMKII-β may contribute to malignant progression of OC through its association with RAS-related signaling, and tannic acid shows pre-clinical preliminary anti-tumor activity associated with CaMKII-β-related signaling in OC. Further mechanistic validation, pharmacokinetic, toxicological, and clinically relevant in vivo studies are required to evaluate its translational potential.

CellsVol. 15(22)
Shanxi Medical University (CN), Shanxi University (CN), Taiyuan University of Technology (CN)
Taiyuan University of Technology
Good health and well-being
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon